|
|
Résultats pour
 marques
1.
|
CAMZYOS
| Numéro d'application |
223777000 |
| Statut |
En instance |
| Date de dépôt |
2023-02-06 |
| Propriétaire |
MyoKardia, Inc. (USA)
|
| Classes de Nice ? |
05 - Produits pharmaceutiques, vétérinaires et hygièniques
|
Produits et services
(1) Pharmaceutical preparations for human use.
|
2.
|
VORZYOS
| Numéro d'application |
214544100 |
| Statut |
En instance |
| Date de dépôt |
2021-11-05 |
| Propriétaire |
MyoKardia, Inc. (USA)
|
| Classes de Nice ? |
05 - Produits pharmaceutiques, vétérinaires et hygièniques
|
Produits et services
(1) Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, heart failure, thrombosis, stroke, cancer, respiratory diseases, auto-immune diseases, rheumatoid arthritis, lupus, inflammatory bowel disease, solid organ transplant rejection, hepatitis, fibrosis, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; pharmaceutical preparations for human use for the treatment and prevention of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, anti-inflammatories, anti-infectives, central nervous system depressants, central nervous system stimulants, anti-psychotics, cytokine inhibitory drugs, anticoagulants; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for the treatment of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for use as anti-infectives, and for use as anti-inflammatories; diagnostic pharmaceutical preparations for human use for increasing the heart rate and for use as medical imaging contrast agents; pharmaceutical preparations for human use that modulate the immune system; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of cancer; pharmaceutical and biological preparations for use in immunotherapies; pharmaceutical and biological preparations for use in T-cell immunotherapy; pharmaceutical and biological preparations for use in cell therapy; pharmaceutical and biological preparations for human use namely T-cells for medical purposes and T-cells for clinical laboratory use; pharmaceutical preparations for human use namely diagnostic kits consisting primarily of cells for medical laboratory use; Pharmaceutical preparations for human use for treatment and prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use namely antivirals for treatment and prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; pharmaceutical preparations for human use namely monoclonal antibodies; pharmaceutical preparations for the treatment of neuropsychiatric disorders; therapeutic radiopharmaceutical preparations for the treatment of cancer and solid tumors; diagnostic radiopharmaceutical preparations; radiopharmaceutical imaging and detection agents for diagnosing and monitoring cancer; radio-isotope markers for therapeutic or diagnostic use; radiopharmaceuticals; Pharmaceutical preparations for human use for the treatment of Cystic Fibrosis
|
3.
|
PAZNYOS
| Numéro d'application |
214543400 |
| Statut |
En instance |
| Date de dépôt |
2021-11-05 |
| Propriétaire |
MyoKardia, Inc. (USA)
|
| Classes de Nice ? |
05 - Produits pharmaceutiques, vétérinaires et hygièniques
|
Produits et services
(1) Pharmaceutical and biological preparations for human use.
|
4.
|
QZIO
| Numéro d'application |
214543500 |
| Statut |
En instance |
| Date de dépôt |
2021-11-05 |
| Propriétaire |
MyoKardia, Inc. (USA)
|
| Classes de Nice ? |
05 - Produits pharmaceutiques, vétérinaires et hygièniques
|
Produits et services
(1) Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, heart failure, thrombosis, stroke, cancer, respiratory diseases, auto-immune diseases, rheumatoid arthritis, lupus, inflammatory bowel disease, solid organ transplant rejection, hepatitis, fibrosis, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; pharmaceutical preparations for human use for the treatment and prevention of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, anti-inflammatories, anti-infectives, central nervous system depressants, central nervous system stimulants, anti-psychotics, cytokine inhibitory drugs, anticoagulants; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for the treatment of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for use as anti-infectives, and for use as anti-inflammatories; diagnostic pharmaceutical preparations for human use for increasing the heart rate and for use as medical imaging contrast agents; pharmaceutical preparations for human use that modulate the immune system; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of cancer; pharmaceutical and biological preparations for use in immunotherapies; pharmaceutical and biological preparations for use in T-cell immunotherapy; pharmaceutical and biological preparations for use in cell therapy; pharmaceutical and biological preparations for human use namely T-cells for medical purposes and T-cells for clinical laboratory use; pharmaceutical preparations for human use namely diagnostic kits consisting primarily of cells for medical laboratory use; Pharmaceutical preparations for human use for treatment and prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use namely antivirals for treatment and prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; pharmaceutical preparations for human use namely monoclonal antibodies; pharmaceutical preparations for the treatment of neuropsychiatric disorders; therapeutic radiopharmaceutical preparations for the treatment of cancer and solid tumors; diagnostic radiopharmaceutical preparations; radiopharmaceutical imaging and detection agents for diagnosing and monitoring cancer; radio-isotope markers for therapeutic or diagnostic use; radiopharmaceuticals; Pharmaceutical preparations for human use for the treatment of Cystic Fibrosis
|
5.
|
PAKZYOS
| Numéro d'application |
214543000 |
| Statut |
En instance |
| Date de dépôt |
2021-11-05 |
| Propriétaire |
MyoKardia, Inc. (USA)
|
| Classes de Nice ? |
05 - Produits pharmaceutiques, vétérinaires et hygièniques
|
Produits et services
(1) Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, heart failure, thrombosis, stroke, cancer, respiratory diseases, auto-immune diseases, rheumatoid arthritis, lupus, inflammatory bowel disease, solid organ transplant rejection, hepatitis, fibrosis, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; pharmaceutical preparations for human use for the treatment and prevention of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, anti-inflammatories, anti-infectives, central nervous system depressants, central nervous system stimulants, anti-psychotics, cytokine inhibitory drugs, anticoagulants; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for the treatment of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for use as anti-infectives, and for use as anti-inflammatories; diagnostic pharmaceutical preparations for human use for increasing the heart rate and for use as medical imaging contrast agents; pharmaceutical preparations for human use that modulate the immune system; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of cancer; pharmaceutical and biological preparations for use in immunotherapies; pharmaceutical and biological preparations for use in T-cell immunotherapy; pharmaceutical and biological preparations for use in cell therapy; pharmaceutical and biological preparations for human use namely T-cells for medical purposes and T-cells for clinical laboratory use; pharmaceutical preparations for human use namely diagnostic kits consisting primarily of cells for medical laboratory use; Pharmaceutical preparations for human use for treatment and prevention of covid 19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use namely antivirals for treatment and prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; pharmaceutical preparations for human use namely monoclonal antibodies; pharmaceutical preparations for the treatment of neuropsychiatric disorders; therapeutic radiopharmaceutical preparations for the treatment of cancer and solid tumors; diagnostic radiopharmaceutical preparations; radiopharmaceutical imaging and detection agents for diagnosing and monitoring cancer; radio-isotope markers for therapeutic or diagnostic use; radiopharmaceuticals; Pharmaceutical preparations for human use for the treatment of Cystic Fibrosis
|
6.
|
TUFYOS
| Numéro d'application |
214543600 |
| Statut |
En instance |
| Date de dépôt |
2021-11-05 |
| Propriétaire |
MyoKardia, Inc. (USA)
|
| Classes de Nice ? |
05 - Produits pharmaceutiques, vétérinaires et hygièniques
|
Produits et services
(1) Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, heart failure, thrombosis, stroke, cancer, respiratory diseases, auto-immune diseases, rheumatoid arthritis, lupus, inflammatory bowel disease, solid organ transplant rejection, hepatitis, fibrosis, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; pharmaceutical preparations for human use for the treatment and prevention of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, anti-inflammatories, anti-infectives, central nervous system depressants, central nervous system stimulants, anti-psychotics, cytokine inhibitory drugs, anticoagulants; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for the treatment of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for use as anti-infectives, and for use as anti-inflammatories; diagnostic pharmaceutical preparations for human use for increasing the heart rate and for use as medical imaging contrast agents; pharmaceutical preparations for human use that modulate the immune system; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of cancer; pharmaceutical and biological preparations for use in immunotherapies; pharmaceutical and biological preparations for use in T-cell immunotherapy; pharmaceutical and biological preparations for use in cell therapy; pharmaceutical and biological preparations for human use namely T-cells for medical purposes and T-cells for clinical laboratory use; pharmaceutical preparations for human use namely diagnostic kits consisting primarily of cells for medical laboratory use; Pharmaceutical preparations for human use for treatment and prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use namely antivirals for treatment and prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; pharmaceutical preparations for human use namely monoclonal antibodies; pharmaceutical preparations for the treatment of neuropsychiatric disorders; therapeutic radiopharmaceutical preparations for the treatment of cancer and solid tumors; diagnostic radiopharmaceutical preparations; radiopharmaceutical imaging and detection agents for diagnosing and monitoring cancer; radio-isotope markers for therapeutic or diagnostic use; radiopharmaceuticals; Pharmaceutical preparations for human use for the treatment of Cystic Fibrosis
|
7.
|
ONKAPSITI
| Numéro d'application |
214536600 |
| Statut |
En instance |
| Date de dépôt |
2021-11-04 |
| Propriétaire |
MyoKardia, Inc. (USA)
|
| Classes de Nice ? |
05 - Produits pharmaceutiques, vétérinaires et hygièniques
|
Produits et services
(1) Pharmaceutical and biological preparations for human use.
|
8.
|
OPZYOS
| Numéro d'application |
214537100 |
| Statut |
En instance |
| Date de dépôt |
2021-11-04 |
| Propriétaire |
MyoKardia, Inc. (USA)
|
| Classes de Nice ? |
05 - Produits pharmaceutiques, vétérinaires et hygièniques
|
Produits et services
(1) Pharmaceutical and biological preparations for human use.
|
9.
|
KAMBEXTRU
| Numéro d'application |
214535700 |
| Statut |
En instance |
| Date de dépôt |
2021-11-04 |
| Propriétaire |
MyoKardia, Inc. (USA)
|
| Classes de Nice ? |
05 - Produits pharmaceutiques, vétérinaires et hygièniques
|
Produits et services
(1) Pharmaceutical and biological preparations for human use.
|
10.
|
MYMODFA
| Numéro d'application |
214536200 |
| Statut |
En instance |
| Date de dépôt |
2021-11-04 |
| Propriétaire |
MyoKardia, Inc. (USA)
|
| Classes de Nice ? |
05 - Produits pharmaceutiques, vétérinaires et hygièniques
|
Produits et services
(1) Pharmaceutical and biological preparations for human use.
|
11.
|
EVMYGO
| Numéro d'application |
214535300 |
| Statut |
En instance |
| Date de dépôt |
2021-11-04 |
| Propriétaire |
MyoKardia, Inc. (USA)
|
| Classes de Nice ? |
05 - Produits pharmaceutiques, vétérinaires et hygièniques
|
Produits et services
(1) Pharmaceutical and biological preparations for human use.
|
12.
|
KOPOZGO
| Numéro d'application |
214536000 |
| Statut |
En instance |
| Date de dépôt |
2021-11-04 |
| Propriétaire |
MyoKardia, Inc. (USA)
|
| Classes de Nice ? |
05 - Produits pharmaceutiques, vétérinaires et hygièniques
|
Produits et services
(1) Pharmaceutical and biological preparations for human use.
|
13.
|
CAMZYOS
| Numéro d'application |
211771700 |
| Statut |
Enregistrée |
| Date de dépôt |
2021-06-30 |
| Date d'enregistrement |
2023-08-09 |
| Propriétaire |
MyoKardia, Inc. (USA)
|
| Classes de Nice ? |
05 - Produits pharmaceutiques, vétérinaires et hygièniques
|
Produits et services
(1) Pharmaceutical preparations for prevention and treatment of cardiovascular diseases and disorders
|
14.
|
CAMZYOS
| Numéro d'application |
202366200 |
| Statut |
Enregistrée |
| Date de dépôt |
2020-04-21 |
| Date d'enregistrement |
2023-08-09 |
| Propriétaire |
MyoKardia, Inc. (USA)
|
| Classes de Nice ? |
05 - Produits pharmaceutiques, vétérinaires et hygièniques
|
Produits et services
(1) Pharmaceutical preparations for prevention and treatment of cardiovascular diseases and disorders
|
15.
|
MYOKARDIA
| Numéro d'application |
201207600 |
| Statut |
En instance |
| Date de dépôt |
2020-02-14 |
| Propriétaire |
MyoKardia, Inc. (USA)
|
| Classes de Nice ? |
- 05 - Produits pharmaceutiques, vétérinaires et hygièniques
- 36 - Services financiers, assurances et affaires immobilières
- 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.
|
Produits et services
(1) Pharmaceutical preparations for prevention and treatment of cardiovascular diseases and disorders (1) Providing funding and research grants to researchers and clinicians for supporting original research
(2) Providing an internet-based international repository namely, a database featuring clinical and laboratory data in the field of cardiovascular diseases and disorders; providing information in the fields of health and medicine namely in the field of diagnosis, prevention, and medical treatment of cardiovascular diseases and disorders; providing medical information in the field of pharmaceuticals, namely, providing medical information in the field of pharmaceutical preparations for the treatment of cardiovascular diseases and disorders
|
16.
|
MYOKARDIA
| Numéro d'application |
197700400 |
| Statut |
En instance |
| Date de dépôt |
2019-07-23 |
| Propriétaire |
MyoKardia, Inc. (USA)
|
| Classes de Nice ? |
- 05 - Produits pharmaceutiques, vétérinaires et hygièniques
- 36 - Services financiers, assurances et affaires immobilières
- 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.
|
Produits et services
(1) Pharmaceutical preparations for prevention and treatment of cardiovascular diseases and disorders (1) Providing funding and research grants to researchers and clinicians for supporting original research
(2) Providing an international repository, namely, a database featuring patient clinical and laboratory data for use by patients and families, health care providers, and medical professionals in the field of cardiovascular diseases and disorders; providing information regarding cardiovascular diseases and disorders for use by patients and families regarding prevention and treatment of cardiovascular diseases and disorders
|
|
